These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33199517)

  • 1. An Analytical Strategy Based on Multiple Complementary and Orthogonal Chromatographic and Detection Methods (Multidetector Approach) to Effectively Manage the Analytical Evaluation Threshold (AET).
    Jordi M; Heise T
    PDA J Pharm Sci Technol; 2021; 75(3):289-301. PubMed ID: 33199517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation.
    Jenke D; Heise T
    PDA J Pharm Sci Technol; 2021; 75(3):273-288. PubMed ID: 33199516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing relative response factor variation using a multidetector approach for extractables and leachables (E&L) analysis to mitigate the need for uncertainty factors.
    Jordi MA; Rowland K; Liu W; Cao X; Zong J; Ren Y; Liang Z; Zhou X; Louis M; Lerner K
    J Pharm Biomed Anal; 2020 Jul; 186():113334. PubMed ID: 32387747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Practical Derivation of the Uncertainty Factor Applied to Adjust the Extractables/Leachables Analytical Evaluation Threshold (AET) for Response Factor Variation.
    Jenke D; Christiaens P; Beusen JM; Verlinde P; Baeten J
    PDA J Pharm Sci Technol; 2022; 76(3):178-199. PubMed ID: 34782443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correcting the Analytical Evaluation Threshold (AET) and Reported Extractable's Concentrations for Analytical Response Factor Uncertainty Associated with Chromatographic Screening for Extractables/Leachables.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(3):348-358. PubMed ID: 32295860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and quantification of medical device extractables and leachables via non-target analysis (NTA); Analytical uncertainty.
    Jenke D; Christiaens P; Heise T
    J Pharm Biomed Anal; 2024 Apr; 241():115985. PubMed ID: 38301578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of Chromatographic Screening Methods for Organic Extractables and Leachables by Managing Outcomes.
    Jenke D
    PDA J Pharm Sci Technol; 2023; 77(4):329-338. PubMed ID: 37001885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative assessment of extractables from single-use components and the impact of reference standard selection.
    Jordi MA; Khera S; Roland K; Jiang L; Solomon P; Nelson J; Lateef SS; Woods J; Martin L; Martin S; Aiello F; Chen N
    J Pharm Biomed Anal; 2018 Feb; 150():368-376. PubMed ID: 29287264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of Omission.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):90-107. PubMed ID: 31209164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the PQRI Extractables and Leachables "Safety Thresholds and Best Practices" Recommendations for Inhalation Drug Products.
    Norwood DL; Nagao LM; Stults CL
    PDA J Pharm Sci Technol; 2013; 67(5):413-29. PubMed ID: 24084658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Retention Time and/or Structure Matching a Solution to the Challenge of Providing Quantitative Data When Screening for Extractables and Leachables by GC/MS?
    Jenke D; Christiaens P; Verlinde P; Baeten J; Beusen JM
    PDA J Pharm Sci Technol; 2022; 76(3):236-247. PubMed ID: 34782445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of internal standard response factors to estimate the concentration of organic compounds leached from pharmaceutical packaging systems and application of such estimated concentrations to safety assessment.
    Jenke D; Odufu A
    J Chromatogr Sci; 2012 Mar; 50(3):206-12. PubMed ID: 22337797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 2-Errors of Inexact Identification and Inaccurate Quantitation.
    Christiaens P; Beusen JM; Verlinde P; Baeten J; Jenke D
    PDA J Pharm Sci Technol; 2020; 74(1):108-133. PubMed ID: 31308065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
    Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
    PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of TOC Reconciliation as a Means of Establishing the Degree to Which Chromatographic Screening of Plastic Material Extracts for Organic Extractables Is Complete.
    Jenke D; Couch TR; Robinson SJ; Volz TJ; Colton RH
    PDA J Pharm Sci Technol; 2014; 68(3):256-70. PubMed ID: 25188347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extractables Screening of Polypropylene Resins Used in Pharmaceutical Packaging for Safety Hazards.
    Jenke D
    PDA J Pharm Sci Technol; 2017; 71(5):346-367. PubMed ID: 28512176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Product Quality Research Institute (PQRI) Leachables and Extractables Working Group Initiatives for Parenteral and Ophthalmic Drug Product (PODP).
    Paskiet D; Jenke D; Ball D; Houston C; Norwood DL; Markovic I
    PDA J Pharm Sci Technol; 2013; 67(5):430-47. PubMed ID: 24084659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Quantitation Classifications for Extractables and Leachables.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(2):275-285. PubMed ID: 31420509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How sensitive does chemical characterization of medical devices need to be? Calibration of analytical evaluation thresholds with the carcinogenic potency database.
    Kennedy TA; Spinti MJ
    Regul Toxicol Pharmacol; 2021 Jun; 122():104899. PubMed ID: 33621616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.